home / stock / sabs / sabs short
Short Information | SAB Biotherapeutics Inc. (NASDAQ:SABS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 11,308 |
Total Actual Volume | 67,111 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 1 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 565 |
Average Short Percentage | 15.63% |
Is there a SABS Short Squeeze or Breakout about to happen?
See the SABS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-26-2024 | $4.1 | $4.2499 | $4.3946 | $4.1 | 4,877 | 1,456 | 29.85% |
04-25-2024 | $4.01 | $4.01 | $4.01 | $4.01 | 794 | 33 | 4.16% |
04-24-2024 | $4.4001 | $4.4 | $4.4001 | $4.4 | 731 | 64 | 8.76% |
04-23-2024 | $4.38 | $4.36 | $4.39 | $4.36 | 858 | 14 | 1.63% |
04-22-2024 | $4.505 | $4.39 | $4.65 | $4.36 | 1,741 | 52 | 2.99% |
04-19-2024 | $4.31 | $4.29 | $4.31 | $4.29 | 891 | 71 | 7.97% |
04-18-2024 | $4.34 | $4.46 | $4.7062 | $4.34 | 2,927 | 467 | 15.95% |
04-17-2024 | $4.37 | $4.6 | $4.8499 | $4.34 | 3,644 | 766 | 21.02% |
04-16-2024 | $4.94 | $4.88 | $4.94 | $4.5301 | 6,922 | 504 | 7.28% |
04-15-2024 | $4.78 | $4.61 | $4.78 | $4.6 | 3,060 | 125 | 4.08% |
04-12-2024 | $4.61 | $4.675 | $4.675 | $4.5401 | 3,497 | 1,080 | 30.88% |
04-11-2024 | $4.5 | $4.5 | $4.5 | $4.5 | 688 | 13 | 1.89% |
04-10-2024 | $4.49 | $4.55 | $4.55 | $4.49 | 2,579 | 522 | 20.24% |
04-09-2024 | $4.492 | $4.46 | $4.492 | $4.46 | 1,609 | 164 | 10.19% |
04-08-2024 | $4.25 | $4.46 | $4.46 | $4.25 | 1,014 | 300 | 29.59% |
04-05-2024 | $4.45 | $4.34 | $4.62 | $4.2501 | 4,071 | 2,117 | 52% |
04-04-2024 | $4.5463 | $4.42 | $4.5463 | $4.25 | 9,005 | 340 | 3.78% |
04-03-2024 | $4.834 | $4.46 | $4.857 | $4.46 | 4,288 | 1,572 | 36.66% |
04-02-2024 | $4.72 | $4.5 | $4.72 | $4.4694 | 8,491 | 1,006 | 11.85% |
04-01-2024 | $4.51 | $4.29 | $4.51 | $4.26 | 5,424 | 642 | 11.84% |
News, Short Squeeze, Breakout and More Instantly...
SAB Biotherapeutics Inc. Company Name:
SABS Stock Symbol:
NASDAQ Market:
MIAMI BEACH, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIg...
MIAMI BEACH, Fla., April 08, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), ("SAB" or the "Company"), a clinical-stage biop...
MIAMI BEACH, Fla., April 08, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIg...